Aclarion, Inc.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
ACON$1.75+5.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Cash Flows
| Nine Months Ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net loss | $(8,223,161) | $(5,344,487) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 186,353 | 166,093 |
| Share-based compensation | 531,632 | 101,003 |
| Amendment of warrants | – | 48,087 |
| Non-cash settlements | – | 58,272 |
| Change in fair value related to warrants and derivative | (30) | (11,767) |
| Change in operating assets and liabilities | ||
| Accounts receivable | (3,563) | (13,692) |
| Prepaids and other current assets | (7,727) | (164,100) |
| Accounts payable | (89,204) | (214,007) |
| Accrued and other liabilities | 288,063 | (162,168) |
| Net cash used in operating activities | (7,317,637) | (5,536,766) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Intangible assets – Patents | (163,546) | (154,639) |
| Fixed assets | (1,808) | (7,802) |
| Net cash used in investing activities | (165,354) | (162,441) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Public offering of common stock and warrants | – | 14,554,545 |
| Registered direct offerings of common stock | 1,036,000 | 5,167,927 |
| Proceeds from direct offering of prefunded warrants | 9,323,982 | – |
| Common stock cash issuance costs | (705,214) | (2,243,441) |
| Exercise of Series C warrants | – | 336,441 |
| Redemption of Series B Preferred stock | – | (1,213,590) |
| Net cash provided by financing activities | 9,654,768 | 16,601,882 |
| Net increase in cash and cash equivalents | 2,171,777 | 10,902,675 |
| Cash, cash equivalents and restricted cash, beginning of period | 12,040,789 | 463,661 |
| Cash, cash equivalents and restricted cash, end of period | $14,212,566 | $11,366,336 |
| Cash paid for interest | $– | $– |
| Cash paid for income taxes | $1,044 | $– |
| Non-cash activities | ||
| Capitalization of Series B preferred stock dividends | $– | $5,425 |
| Capitalization of Series C preferred stock dividends | $– | $1,258 |
| Conversion of Series C preferred stock to common stock | $– | $548,534 |
| Cashless exercise of B warrants to common stock | $– | $9,539,081 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.